Government Wide Acquisition Contract (GWAC) 75F40120D00007

Award Date 1/13/20
Last Date to Order 1/12/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
Caitta Inc. was awarded a single award, 8(a) set aside indefinite delivery contract from the Department of Health and Human Services' Food and Drug Administration. The contract has a potential value of $738,000 and a period of performance through September 2023. Under the contract, Caitta will provide benefit, risk, and quality assessment services to support the FDA's public health and regulatory functions. Specifically, the company will leverage its expertise in areas such as clinical trials,...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a single-award indefinite delivery contract to Caitta Inc., an SBA certified 8(a) economically disadvantaged woman-owned small business. The $203,440.70 contract, with a period of performance ending on June 30, 2017, is for Caitta to provide scientific, technical, and administrative services to federal health agencies. Through this contract and related task orders, Caitta has supplied the Food and...
The Federal Supply Schedule contract 47QRAA22D0071 was awarded by the General Services Administration's Federal Acquisition Service to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant. The $2 million, 5-year contract enables Caitta to provide epidemiological, public health, research, and administrative services to civilian federal agencies across 20 labor categories. Key services include epidemiology support, public...
The Department of Health and Human Services Food and Drug Administration awarded a single-award Indefinite Delivery Contract (IDC) valued at $4,000,000 to Fedpoint Systems LLC, a minority-owned and woman-owned small disadvantaged business. The contract, set aside for 8(a) participants, is for the procurement of Liquid Chromatograph Triple Quadrupole Mass Spectrometers to support the FDA's regulatory science and product safety missions. To date, the FDA has issued two delivery orders against...
The Department of Health and Human Services Food and Drug Administration awarded a blanket purchase agreement to Agilent Technologies Inc. under the company's GSA Multiple Award Schedule contract. The BPA establishes a single award vehicle for the delivery of gas chromatograph triple quadrupole mass spectrometers to support FDA analytical testing programs. Three firm fixed price call contracts were placed against the BPA between 2020 and 2021, totaling $1,796,332, for the delivery of mass...
The Department of Health and Human Services Food and Drug Administration awarded a single-award, $9.5 million blanket purchase agreement to Thermo Electron North America LLC to obtain mass spectrometry and liquid chromatography systems with related services. Under the agreement, the FDA issued a firm fixed price call contract valued at $830,588.14 to Thermo Electron North America LLC for two high-resolution mass spectrometry-ultra high performance liquid chromatography systems, including...
The Department of Health and Human Services Food and Drug Administration awarded an indefinite delivery, indefinite quantity contract to Koniag Management Solutions LLC with a potential value of $25,000,000. Task orders issued against the contract procure scientific support services including research, laboratory analysis, and subject matter expertise to support the FDA's regulatory, compliance and public health programs. Task orders awarded to Koniag Management Solutions LLC and described in...
The Indefinite Delivery Contract (IDC) with ID 75F40119D10009 was awarded by the U.S. Food and Drug Administration (FDA), a civilian agency, to Fedpoint Systems LLC, a minority-owned small disadvantaged business that is an 8(a) Program participant. The contract's initial delivery order, valued at $1,327,372.60, is for the provision of HPLC ION TRAP MS SYSTEMS, a type of analytical instrumentation used by the FDA to regulate food and drugs. The period of performance for this firm fixed price...
The Department of Health and Human Services Food and Drug Administration (FDA) awarded a single-award Indefinite Delivery Contract (IDC) to AB Sciex LLC, a division of Danaher Corporation, for a 5-year maintenance and service contract for liquid chromatography-tandem mass spectrometers (LC-MS/MS). The contract has a ceiling value of $2,503,000 and a period of performance through April 23, 2029. Under this IDC, the FDA awarded a $225,566.45 Firm Fixed Price Delivery Order to AB Sciex LLC for an...
The Department of Health and Human Services Food and Drug Administration awarded a blanket purchase agreement to AB Sciex LLC, a division of Danaher Corporation, to procure ultra-sensitive liquid chromatography-triple quadrupole mass spectrometry systems with ion-trap capabilities. Under multiple call contracts against this agreement totaling over $12M, AB Sciex will provide 29 mass spectrometry systems and 11 nitrogen generators to support FDA's regulatory science and public health protection...
  • 75F40120D00007
    Government Wide Acquisition Contract (GWAC)
  • 2
    Federal Contract Awards

The Department of Health and Human Services Food and Drug Administration awarded a multiple-award Government Wide Acquisition Contract to Caitta Inc., an SBA Certified 8A Program Participant, with a potential value of $999,000.00. The contract aims to procure portable thermal desorption-ambient ionization-mass detector systems to support the agency's regulatory product testing and analysis efforts.

Under the contract, Caitta Inc. received two delivery orders for portable mass spectrometers. The first was awarded on February 24, 2022 for $183,561 to provide a system for the FDA's Miami location, with work completed by February 27, 2023. The second was awarded on February 27, 2020 for $174,621.30 to provide a system for the FDA's Lisle, Illinois office, with work finished by February 26, 2021. Both orders were firm fixed price with no set-aside designation applied. The detector systems support the FDA's mass spectrometry needs to detect and analyze chemical compounds in regulated products without sample preparation.

Generated 1/5/24, 7:30 PM